Allergan

AbbVie said on Tuesday that it’s buying Botox-maker Allergan in a $63 billion deal. The deal could generate as much as $183 million in fees for thebanks that worked on the deal, according to...

AbbVie is buying Botox-maker Allergan in a $63 billion deal,the companies said on Tuesday. The deal would combine AbbVie, which makes the blockbuster drug Humira, with Allergan, whichhas been facing...